Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Discovers New Genes, Receives More Patents on BRCA1

Premium

SALT LAKE CITY--Myriad Genetics here has announced three new gene discoveries and gained two more patents on the BRCA1 gene. In addition, the company is suing OncorMed for patent infringement relating to one of the new patents.

The gene discoveries could open the door for developing new cancer treatments, according to Myriad. They were made using the company's ProNet protein interaction technology that rapidly identifies proteins with potential therapeutic value, Myriad said, and are the first demonstration of the technology's capability.

The new genes have been labeled MMSC1, CtIP, and MKK3. MMSC1 "appears to interact directly with the MMAC1 brain and prostate cancer gene that was identified by Myriad scientists in January 1997," the company claimed, while CtIP has been linked to the pathway of BRCA1. MKK3 acts as a tumor suppressor in lung cancer.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.